[1] Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019; 140: 1156−1169. doi: 10.1161/CIRCULATIONAHA.119.041080 [2] El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging 2018; 11: 628−643. doi: 10.1016/j.jcmg.2018.01.009 [3] Kihara Y, Sasayama S, Miyazaki S, et al. Role of the left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogs. Circ Res 1988; 62: 543−553. doi: 10.1161/01.RES.62.3.543 [4] Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 2009; 54: 1961−1968. doi: 10.1016/j.jacc.2009.06.047 [5] Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561−632. doi: 10.1093/eurheartj/ehab395 [6] Essayagh B, Antoine C, Benfari G, et al. Prognostic implications of left atrial enlargement in degenerative mitral regurgitation. J Am Coll Cardiol 2019; 74: 858−870. doi: 10.1016/j.jacc.2019.06.032 [7] Rusinaru D, Tribouilloy C, Grigioni F, et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 2011; 4: 473−481. doi: 10.1161/CIRCIMAGING.110.961011 [8] Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2009; 2: 191−198. doi: 10.1161/CIRCIMAGING.108.819938 [9] Donekal S, Venkatesh BA, Liu YC, et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circ Cardiovasc Imaging 2014; 7: 292−302. doi: 10.1161/CIRCIMAGING.113.001073 [10] Boyle AJ, Shih H, Hwang J, et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 2011; 46: 549−559. doi: 10.1016/j.exger.2011.02.010 [11] Fujimoto N, Hastings JL, Bhella PS, et al. Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol 2012; 590: 1871−1880. doi: 10.1113/jphysiol.2011.218271 [12] Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110: 1799−1805. doi: 10.1161/01.CIR.0000142863.71285.74 [13] Redfield MM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005; 112: 2254−2262. doi: 10.1161/CIRCULATIONAHA.105.541078 [14] Pan NH, Tsao HM, Chang NC, et al. Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest 2008; 133: 190−196. doi: 10.1378/chest.07-1769 [15] Rønningen PS, Berge T, Solberg MG, et al. Sex differences and higher upper normal limits for left atrial end-systolic volume in individuals in their mid-60s: data from the ACE 1950 Study. Eur Heart J Cardiovasc Imaging 2020; 21: 501−507. doi: 10.1093/ehjci/jeaa004 [16] McManus DD, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community. Circulation 2010; 121: 667−674. doi: 10.1161/CIRCULATIONAHA.109.885806 [17] Avierinos JF, Tribouilloy C, Grigioni F, et al. Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study. Eur Heart J 2013; 34: 2600−2608. doi: 10.1093/eurheartj/eht250 [18] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233−270. doi: 10.1093/ehjci/jev014 [19] Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013; 14: 611−644. doi: 10.1093/ehjci/jet105 [20] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e72−e227. doi: 10.1161/CIR.0000000000000923 [21] Namazi F, van der Bijl P, Vo NM, et al. Sex differences in prognosis of significant secondary mitral regurgitation. ESC Heart Fail 2021; 8: 3539−3546. doi: 10.1002/ehf2.13503 [22] [23] Kammerlander AA, Donà C, Nitsche C, et al. Sex differences in left ventricular remodeling and outcomes in chronic aortic regurgitation. J Clin Med 2020; 9: 4100. doi: 10.3390/jcm9124100 [24] Tastet L, Kwiecinski J, Pibarot P, et al. Sex-related differences in the extent of myocardial fibrosis in patients with aortic valve stenosis. JACC Cardiovasc Imaging 2020; 13: 699−711. doi: 10.1016/j.jcmg.2019.06.014